Home > Cashflow Statement > NGL FINECHEM

NGL FINECHEM
Cashflow Statement

NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹28 Cr₹54 Cr₹27 Cr₹67 Cr₹78 Cr
Adjustment ₹14 Cr₹12 Cr₹12 Cr₹11 Cr₹4.73 Cr
Changes In working Capital ₹0.98 Cr₹-33 Cr₹3.26 Cr₹-47 Cr₹-34 Cr
Cash Flow after changes in Working Capital ₹42 Cr₹34 Cr₹42 Cr₹31 Cr₹48 Cr
Cash Flow from Operating Activities ₹36 Cr₹20 Cr₹35 Cr₹14 Cr₹27 Cr
Cash Flow from Investing Activities ₹-35 Cr₹-27 Cr₹-27 Cr₹-14 Cr₹-25 Cr
Cash Flow from Financing Activities ₹-1.08 Cr₹-1.08 Cr₹-1.08 Cr₹-1.08 Cr₹-1.08 Cr
Net Cash Inflow / Outflow ₹0.19 Cr₹-7.43 Cr₹7.18 Cr₹-1.46 Cr₹1.70 Cr
Opening Cash & Cash Equivalents ₹0.40 Cr₹7.83 Cr₹0.64 Cr₹2.10 Cr₹0.40 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹0.58 Cr₹0.40 Cr₹7.83 Cr₹0.64 Cr₹2.10 Cr

Compare Cashflow Statement of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹946.1 Cr 5.4% 16.5% -10.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,773.0 Cr -6.8% -7.6% -4.7% Stock Analytics
DIVIS LABORATORIES ₹159,540.0 Cr -6.6% -5.8% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,529.0 Cr 0.9% 5.7% 27.3% Stock Analytics
CIPLA ₹111,299.0 Cr -4.8% -8.1% -3.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,393.0 Cr -2% -8.8% -12.9% Stock Analytics


NGL FINECHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

5.4%

16.5%

-10.5%

SENSEX

-2%

-2.8%

7.4%


You may also like the below Video Courses